ACI & the American Health Lawyers Association are Teaming Up to Bring You the Quintessential 3-part Webinar Series on the 340B Prescription Drug Program.

by -
Prepping for the Rx Drug Pricing Master Course on November 4th to November 6th in New York City’s Carlton Hotel? Be sure to register for our 3-part webinar series! Click the photo below for more information on how to sign up for our October 22nd (2:00 – 3:30 pm EST) webinar with Emily J. Cook, Partner, McDermott Will…

Bristol-Myers Squibb pays $14 million to resolve China FCPA offenses

by -
By Richard L. Cassin, Published on The FCPA Blog on October 5th, 2015 The Securities and Exchange Commission said Monday that Bristol-Myers Squibb agreed to settle charges that its joint venture in China made cash payments and provided other benefits to health care providers at state-owned and state-controlled hospitals in exchange for prescription sales. –…

US Attorney Carmen Ortiz and leading DOJ enforcers to speak at ACI’s Drug and Med

by -
The American Conference Institute (ACI) is pleased to announce that Carmen M. Ortiz, United States Attorney for the District of Massachusetts will participate in an Enforcers’ Spotlight: Understanding Government’s Enforcement Priorities vis-à-vis Drug and Device Products Liability Matters at ACI’s Drug and Med Conference on December 2-4, 2015 at the Millennium Times Square in New…

Hitachi Inspires The Next FCPA Enforcement Action Against A Foreign Company

by -
Published on The FCPA Professor, September 29th, 2015 What happens when a Japanese company has a German-based subsidiary, which in turn has a South African subsidiary, that both allegedly make improper payments to a South African political party? Why of course, $19 million to the U.S. treasury because the Japanese company just happened to have American…